Ovarian Cancer Diagnostic Market Size, Share, Growth Analysis, By Type(Epithelial tumours, germ cell tumours, stromal tumours), By End user(Hospital Laboratories, diagnostic centres, Research Institutes, others), By Region - Industry Forecast 2024-2031

Global Ovarian Cancer Diagnostic Market size was valued at USD 1.57 billion in 2022 and is poised to grow from USD 1.77 billion in 2023 to USD 9.67 billion by 2031, growing at a CAGR of 23.7% in the forecast period (2024-2031).

Ovarian cancer is a type of cancer that occurs in the ovaries; there are several types of ovarian cancer, the most common of which is epithelial ovarian cancer. The primary cause of this type of cancer is uncontrollable cell growth in the ovarian tissue, and it is one of the leading causes of death in women worldwide. It is the fifth most common cause of cancer death in women worldwide, and the tenth most common cause of cancer death in women in the United States. Novel approaches in ovarian cancer treatment is the major factor escalating the market expansion, also increased funding for cancer research, rising in health awareness and increase in aged women population all over the world are the most common factors among others that driving the ovarian cancer diagnostics market. The development and technical advancements in the machines that are used for the treatment can create new opportunities for ovarian cancer diagnostics market in the forecasted period.

Government and research department are focusing on advanced cancer diagnostic methods that could detect the cancer at its early level as the cancer diagnostic methods of present detect the cancer when it has already spread at an advanced level. Rising awareness, increasing focus of government, researchers and other medical organizations to provide convenient and in-time diagnosis of ovarian cancer method are key factors for boosting the market growth.